MELBOURNE-BASED myDNA has raised $10 million in its latest round of capital raising, which has included the backing of Swisse ceo Radek Sali who is joining the genetics company's board.
myDNA chairman Dennis Bastas said "Mr Sali joins our experienced team, bringing a consumer focus to the company's highly credentialed scientific foundations, as we prepare to launch an expanded range of wellness, diet and nutrition tests".
Sali said he believed myDNA represented "the future of health - personalised, tailored health advice that can improve individual health outcomes and allow the health care system to operate more efficiently, all based on robust genetic science".
The above article was sent to subscribers in Pharmacy Daily's issue from 02 May 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 02 May 17
